Answer
Aug 08, 2025 - 10:08 AM
CagriSema works through dual mechanisms: cagrilintide reduces appetite and food intake by acting on amylin and calcitonin receptors, while semaglutide slows gastric emptying and improves insulin secretion as a GLP-1 receptor agonist. These mechanisms are valuable for enhancing weight loss and metabolic control in patients with obesity and diabetes.
